Удк: 61.661-006.63-616-089.844

HIGHLIGHTS

• who: For correspondence et al. from the VNVN. have published the research: u0423u0414u041a: 61.661-006.63-616-089.844, in the Journal: (JOURNAL)
• what: The aim of the treatment of patients with BCC should be considered to be the complete removal of the tumor, moreover, maximal preservation of the function of the involved organ and the best cosmetic results should be achieved. The STEVIE (SafeTy Events in VIsmodEgib) trial, in which the biggest number of patients took part (1215, 1119 with laBCC and 96 with mBCC), had the main aim of determining safety.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.